Concepedia

Publication | Open Access

A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma

43

Citations

46

References

2022

Year

Abstract

This study was registered in ClinicalTrials.gov (NCT03111732).

References

YearCitations

Page 1